CD4+FoxP3+ regulatory T-cells in human systemic lupus erythematosus
被引:17
作者:
Suen, Jau-Ling
论文数: 0引用数: 0
h-index: 0
机构:
Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan
Kaohsiung Med Univ, Coll Med, Fac Med, Dept Microbiol, Kaohsiung, TaiwanKaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan
Suen, Jau-Ling
[1
,2
]
Chiang, Bor-Luen
论文数: 0引用数: 0
h-index: 0
机构:
Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei 10764, TaiwanKaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan
Chiang, Bor-Luen
[3
]
机构:
[1] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Microbiol, Kaohsiung, Taiwan
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immune tolerance to self antigens and by the persistent production of pathogenic autoantibodies. Recent studies have suggested a dysregulation of regulatory T-cells (Tregs), particularly CD4(+)CD25(high)FoxP3(+) (forkhead box P3) Tregs, as one of the major factors conferring the risk for expression of human autoimmune diseases, including SLE. However, detailed studies of CD4(+)FoxP3(+) T-cells in patients with SLE remain limited. We attempt here to integrate the current experimental evidence to delineate the role of CD4(+)CD25(hlgh) and other subsets of CD4(+)FoxP3(+) T-cells in human SLE. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.